TF
HAE icon

Tompkins Financial’s Haemonetics HAE Stock Holding History

Tompkins Financial’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-560
Closed -$37K – 602
2022
Q2 		$37K Hold
560
– – 0.01% 358
2022
Q1 		$35K Hold
560
– – ﹤0.01% 384
2021
Q4 		$30K Hold
560
– – 0.01% 248
2021
Q3 		$40K Buy
+560
New +$35.3K 0.01% 240
2021
Q1 		$62K Hold
560
– – 0.01% 229
2020
Q4 		$67K Hold
560
– – 0.01% 213
2020
Q3 		$49K Hold
560
– – 0.01% 236
2020
Q2 		$50K Buy
+560
New +$56.6K 0.01% 229

Other funds holding HAE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Tompkins Financial's HAE Position: Q3 2022 in Review

Tompkins Financial sold out of Haemonetics (HAE) in Q3 2022, closing a stake of 560 shares — an estimated $37K sold.

Tompkins Financial first reported a position in HAE in Q2 2020 and held it in 8 quarters. The position peaked at $67K in Q4 2020. 268 funds tracked by Wall St. Rank hold HAE as of Q3 2022.

  • Tompkins Financial reported no remaining Haemonetics position as of Q3 2022 after selling out during the quarter.
  • Tompkins Financial sold 560 Haemonetics shares in Q3 2022, an estimated $37K.
  • Tompkins Financial first reported a position in Haemonetics in Q2 2020 and held it in 8 quarters.
  • Tompkins Financial's Haemonetics position peaked at $67K in Q4 2020.
  • 268 funds tracked by Wall St. Rank held Haemonetics as of Q3 2022.

Based on Tompkins Financial's 13F filing for Q3 2022, filed 13 Oct 2022.